<i>De novo</i> mutations of <i>BCL11B</i> have been associated with neurodevelopmental disorder and immunodeficiency, such as immunodeficiency 49 (IMD49) and intellectual developmental disorder with speech delay, dysmorphic facies, and T-cell abnormalities (IDDSFTA). This evidence concerns the gene BCL11B and immunodeficiency 49.